申请人:Chemo Ibérica, S.A.
公开号:EP2589587A1
公开(公告)日:2013-05-08
The invention is about a new synthetic pathway for the preparation of enantiomerically pure nitrogen substituted cyclopropanes, in particular the trans-cyclopropanamine (1), a key intermediate in the synthesis of Ticagrelor:
The invention also relates to the processes for preparing said compounds or their salts and the use of said compounds as intermediates in preparing pharmaceutically active ingredients.
这项发明涉及一种新的合成途径,用于制备对映纯的氮取代环丙烷,特别是trans-环丙胺(1),这是Ticagrelor合成中的关键中间体:该发明还涉及制备所述化合物或其盐的过程,以及将所述化合物用作制备药用活性成分的中间体的用途。